Chemoinformaics analysis of CAPRIC-ACID-METHYL-ESTER
| Molecular Weight | 186.295 | nRot | 8 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 1 |
| Exact Molecular Weight | 186.162 | nRing | 0 |
| Solubility: LogS | -4.167 | nHRing | 0 |
| Solubility: LogP | 4.252 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.6434 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.429 |
| Synth | 1.592 |
| Natural Product Likeliness | 0.37 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.592 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.497 |
| MDCK | 0.0000233 |
| BBB | 0.985 |
| PPB | 0.917423 |
| VDSS | 0.587 |
| FU | 0.0854316 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.684 |
| CYP2c19-inh | 0.709 |
| CYP2c19-sub | 0.602 |
| CYP2c9-inh | 0.516 |
| CYP2c9-sub | 0.898 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.126 |
| CYP3a4-inh | 0.182 |
| CYP3a4-sub | 0.134 |
| CL | 7.809 |
| T12 | 0.71 |
| hERG | 0.076 |
| Ames | 0.007 |
| ROA | 0.043 |
| SkinSen | 0.926 |
| Carcinogencity | 0.204 |
| EI | 0.978 |
| Respiratory | 0.698 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.669946 |